Cross-linking of amyloid precursor protein (APP) at the cell surface by antibodies leads to APP internalization via Arf6-depedent macropinocytosis, potentially contributing to Alzheimer's disease (Tang et al., 2015). This evidence concerns the gene APP and Alzheimer disease.